BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu D, Ma X, Liu J, Zhao L, Chen H, Xu L, Sun Z, Fan Z. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine. Int J Cardiovasc Imaging 2017;33:1191-200. [DOI: 10.1007/s10554-017-1101-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Reiber JHC, Alaiti A, Bezerra HG, De Sutter J, Schoenhagen P, Stillman AE, Van de Veire NRL. Cardiovascular imaging 2017 in the International Journal of Cardiovascular Imaging. Int J Cardiovasc Imaging 2018;34:833-48. [DOI: 10.1007/s10554-018-1349-6] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Sakamoto K, Oyama-Manabe N, Manabe O, Aikawa T, Kikuchi Y, Sasai-Masuko H, Naya M, Kudo K, Kato F, Tamaki N, Shirato H. Heterogeneity of longitudinal and circumferential contraction in relation to late gadolinium enhancement in hypertrophic cardiomyopathy patients with preserved left ventricular ejection fraction. Jpn J Radiol 2018;36:103-12. [PMID: 29119456 DOI: 10.1007/s11604-017-0700-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
3 Scott LJ. Gadobutrol: A Review in Contrast-Enhanced MRI and MRA. Clin Drug Investig 2018;38:773-84. [PMID: 30006819 DOI: 10.1007/s40261-018-0674-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
4 Muscogiuri G, Gatti M, Dell’aversana S, Andreini D, Guaricci AI, Guglielmo M, Baggiano A, Mushtaq S, Conte E, Annoni A, Formenti A, Mancini ME, Gripari P, Rabbat MG, Pepi M, Pontone G. Diagnostic Accuracy of Single-shot 2-Dimensional Multisegment Late Gadolinium Enhancement in Ischemic and Nonischemic Cardiomyopathy. Journal of Thoracic Imaging 2020;35:56-63. [DOI: 10.1097/rti.0000000000000402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Sunthankar S, Parra DA, George-Durrett K, Crum K, Chew JD, Christensen J, Raucci FJ, Xu M, Slaughter JC, Soslow JH. Tissue characterisation and myocardial mechanics using cardiac MRI in children with hypertrophic cardiomyopathy. Cardiol Young 2019;29:1459-67. [PMID: 31769372 DOI: 10.1017/S1047951119002397] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Sun Y, Deng D, Sun L, He Y, Wang H, Dong J. Comparison of Segmentation Algorithms for Detecting Myocardial Infarction Using Late Gadolinium Enhancement Magnetic Resonance Imaging. Cardiovascular Innovations and Applications 2020;5:89-95. [DOI: 10.15212/cvia.2019.0574] [Reference Citation Analysis]
7 Wu ZH, Sun LP, Liu YL, Dong DD, Tong L, Deng DD, He Y, Wang H, Sun YB, Dong JZ, Xia L. Fully Automatic Scar Segmentation for Late Gadolinium Enhancement MRI Images in Left Ventricle with Myocardial Infarction. Curr Med Sci 2021;41:398-404. [PMID: 33877559 DOI: 10.1007/s11596-021-2360-z] [Reference Citation Analysis]
8 Park CH, Chung H, Kim Y, Kim JY, Min PK, Lee KA, Yoon YW, Kim TH, Lee BK, Hong BK, Rim SJ, Kwon HM, Choi EY. Electrocardiography based prediction of hypertrophy pattern and fibrosis amount in hypertrophic cardiomyopathy: comparative study with cardiac magnetic resonance imaging. Int J Cardiovasc Imaging 2018;34:1619-28. [PMID: 29728953 DOI: 10.1007/s10554-018-1365-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
9 Richard G, Noll C, Archambault M, Lebel R, Tremblay L, Ait-Mohand S, Guérin B, Blondin DP, Carpentier AC, Lepage M. Contribution of perfusion to the 11 C-acetate signal in brown adipose tissue assessed by DCE-MRI and 68 Ga-DOTA PET in a rat model. Magn Reson Med 2021;85:1625-42. [PMID: 33010059 DOI: 10.1002/mrm.28535] [Reference Citation Analysis]